← Back to Patent Explorer
US5520786A Expired / Lapsed US ⏱️ 0.0 years remaining

Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof

Assignee: Ascensia Diabetes Care Holdings AG
•
Filing: 1995-06-06
•
Granted: 1996-05-28
•
Expires: 2015-06-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is an improved electrode suitable for the electrochemical regeneration of the co-enzymes NADH and NADPH. The electrode has imparted on its surface a mediator function which is a 3-phenylimino-3H-phenothiazine or a 3-phenylimino-3H-phenoxazine. Also disclosed is a method of improving the performance of a biochemical fuel cell which operates with a dehydrogenase as a catalyst and a co-enzyme as the energy-transferring redox couple which involves using the improved electrode in the fuel cell.

Inventors

  • 👤 Michael L. Bloczynski
  • 👤 Paul F. Corey
  • 👤 Yingping Deng
  • 👤 Alison J. Murray
  • 👤 Matthew K. Musho
  • 👤 Hans-Ulrich Siegmund

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 09:32
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/001; C12Q1/004; H; H01; H01M; H01M4/00; H01M4/86; H01M4/90; H01M4/9008; H01M8/00; H01M8/16; Y; Y02; Y02E; Y02E60/00; Y02E60/30; Y02E60/50; Y10; Y10S; Y10S435/00; Y10S435/817

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 52 words
An electrode for the electrochemical regeneration of the coenzymes dihydronicotinamide adenine dinucleotide (NADH), dihydronicotinamide adenine dinucleotide phosphate (NADPH) or analogs thereof characterized in that there has been imparted to the electrode surface a mediator function comprising one or more mediator compound selected from the group of substituted or unsubstituted 3-phenylimino-3H-phenothiazines and 3-phenylimino-3H-phenoxazines.
Claim 2
Dependent Claim 52 words
An electrode for the electrochemical regeneration of the coenzymes dihydronicotinamide adenine dinucleotide (NADH), dihydronicotinamide adenine dinucleotide phosphate (NADPH) or analogs thereof characterized in that there has been imparted to the electrode surface a mediator function comprising one or more mediator compound selected from the group of substituted or unsubstituted 3-phenylimino-3H-phenothiazines and 3-phenylimino-3H-phenoxazines.
Claim 3
Dependent Claim 59 words
An electrode as in claim 1 wherein the mediator is characterized by Formula I or Formula II: ##STR30## wherein R1 and R2 are substituents which serve to modulate the reduction-oxidation (redox) potential of the mediator, to vary the mediator's solubility or to function as a site for the covalent attachment of the mediator to a polymer or solid support.
Claim 4
Dependent Claim 55 words
The electrode of claim 2 wherein R1 and R2, which may be the same or different, are selected from the group consisting of hydrogen, lower alkyl, aryl, halo, haloalkyl, carboxy, carboxyalkyl, alkoxycarbonyl, aryloxycarbonyl, aromatic and aliphatic keto, alkoxy, aryloxy, nitro, dialkylamino, aminoalkyl, sulfo and dihydroxyboron wherein the aliphatic and aromatic groups are substituted or unsubstituted.
Claim 5
Dependent Claim 24 words
The electrode of claim 1 wherein the electrode material is graphite, pyrolytic carbon, glassy carbon, platinum, gold or a composite made from these materials.
Claim 6
Dependent Claim 13 words
The electrode of claim 1 wherein the mediator is attached to a polymer.
Claim 7
Dependent Claim 12 words
The electrode of claim 5 wherein the polymer is poly(methylvinyl ether-co-maleic anhydride).
Claim 8
Dependent Claim 41 words
The electrode of claim 1 wherein the mediator is selected from the group comprised of: 3-(4'-chloro-phenylimino)-3H-phenothiazine, 3-(4'-diethylamino-phenylimino)-3H-phenothiazine, 3-(4'-ethyl-phenylimino)-3H-phenothiazine, 3-(4'-trifluoromethyl-phenylimino)-3H-phenothiazine, 3-(4'-methoxycarbonyl-phenylimino)-3H-phenothiazine, 3-(4'-nitro-phenylimino)-3H-phenothiazine, 3-(4'-methoxy-phenylimino)-3H-phenothiazine, 7-acetyl-3-(4'-methoxycarbonylphenylimino)-3H-phenothiazine, 7-trifluoromethyl-3-(4'-methoxycarbonylphenylimino)-3H-phenothiazine, 3-(4'-ω-carboxy-n-butyl-phenylimino)-3H-phenothiazine, 3-(4'-aminomethyl-phenylimino)-3H-phenothiazine, 3-(4'-(2"-(5"-(p-aminophenyl)-1,3,4-oxadiazoyl)phenylimino)-3H-phenothiazine, 3-(4'-β-aminoethyl-phenylimino)-3H-phenothiazine, 6-(4'-ethylphenyl)amino-3-(4'-ethyl-phenylimino)-3H-phenothiazine, 6-(4'-[2-(2-ethanoloxy)ethoxy]ethoxyphenyl)amino-3-(4'-[2-(2-ethanoloxy)ethoxy]ethoxy-phenylimino)-3H-phenothiazine, 3-(4'-[2-(2-ethanoloxy)ethoxy]ethoxy-phenylimino)-3H-phenothiazine, 3-(4'-phenylimino)-3H-phenothiazineboronic acid, (3-(3',5'-dicarboxy-phenylimino)-3H-phenothiazine, 3-(4'-carboxy-phenylimino)-3H-phenothiazine, 3-(3',5'-dicarboxy-phenylimino)-3H-phenoxazine, 3-(2',5'-phenylimino)-3H-phenothiazinedisulfonic acid, and 3-(3-phenylimino)-3H-phenothiazinesulfonic acid.
Claim 9
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(4'-trifluoromethyl-phenylimino)-3H-phenothiazine.
Claim 10
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(4'-methoxycarbonyl-phenylimino)-3H-phenothiazine.
Claim 11
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(4'-ω-carboxy-n-butyl-phenylimino)-3H-phenothiazine.
Claim 12
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(4'-aminomethyl-phenylimino)-3H-phenothiazine.
Claim 13
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(4'-β-aminoethyl-phenylimino)-3H-phenothiazine.
Claim 14
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(3',5'-dicarboxy-phenylimino)-3H-phenothiazine.
Claim 15
Dependent Claim 10 words
The electrode of claim 7 wherein the mediator is 3-(3',5'-dicarboxy-phenylimino)-3H-phenoxazine
Claim 16
Dependent Claim 11 words
The electrode of claim 7 wherein the mediator is 3-(2',5'-phenylimino)-3H-phenothiazinedisulfonic acid.
Claim 17
Dependent Claim 11 words
The electrode of claim 7 wherein the mediator is 3-(3'-phenylimino)-3H-phenothiazinesulfonic acid.
Claim 18
Dependent Claim 12 words
The electrode of claim 5 wherein the mediator is 3-(4'-aminomethyl-phenylimino)-3H-phenothiazine or 3-(4'-β-aminoethyl-phenylimino)-3H-phenothiazine.
Claim 19
Dependent Claim 12 words
The electrode of claim 6 wherein the mediator is 3-(4'-aminomethyl-phenylimino)-3H-phenothiazine or 3-(4'-β-aminoethyl-phenylimino)-3H-phenothiazine.

References Cited (Backward Citations)

US4490464A Cited
US4710570A Cited
US5373348A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-05-28 1999-11-27 2000-05-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-05-28 2003-11-27 2004-05-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-05-28 2007-11-27 2008-05-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag